<p>(A) Gene targeting strategy and restriction map of TANK1 gene. Filled boxes indicate exons; labeled boxes indicate neomycin (neo) resistance or herpesvirus thymidine kinase (tk) genes; and arrows indicate loxP sites. (B, C) Southern blot analysis of ES cell DNA. The 4.2 kb and 1.5 kb bands represents the germ line alleles and 6.0 kb and 2.5 kb bands represent the targeted alleles when BamHI/XbaI enzymes were used (B). The 12 kb and 1.3 kb bands represent the germ line alleles, and 13.8 kb and 0.8 kb bands represent the targeted alleles when EcoRV was used(c). (D) PCR analysis for the conditional TANK1 knockout mouse genotype. The 340- and 240-bp PCR products represent the wild-type and floxed alleles, respectively. (E) PCR analysis for t...
<p>(A) Gene targeting strategy. The Neomycin (NeoR)/Puromycin (PuroR) selection marker is displayed ...
<p>A. Targeting vector construct <i>pTKLNCL-Cdk2ap1</i> was designed to knockout <i>Cdk2ap1</i> exon...
<p>(A) Illustration of the targeting construct and possible recombination event to produce founder m...
<p><i>A)</i> Diagram illustrating the gene-targeting strategy used to produce αB-R120G gene knock-in...
<p>A) Gene targeting strategy and restriction map of the p53 gene. Filled boxes indicate exons; labe...
<p>A part of the wild type (+) allele of mouse AQP1 is shown with indicated exons (black boxes) and ...
<p>A: Schematic of the construct used for the generation of transgenic mice expressing PA-GFP::NLS u...
<p>(A) ES-cell targeting strategy, adapted from <a href="http://www.plosone.org/article/info:doi/10....
<p>(<b>A</b>) Shows the scheme of the linearized targeting vector used for electroporation in mouse ...
<p>(a). Schematic demonstrating the strategy for targeted integration of exogenous gene(s), wild typ...
<p>(<b>A</b>) Structure of the <i>MCT1</i> wildtype allele, the targeting vector, and the resulting ...
<p>(A, E) Targeting strategies. Restriction maps of relevant genomic regions of <i>Ankrd1</i> (A) an...
<p><i>A. Targeting strategy for generating MLF1-IP KO mice</i> The red square on the 5′ side of the ...
<p>(A) Schematic diagram of the targeting construct. For targeted disruption of the mouse GlcAT-S ge...
<p><b>A</b>) Top: Scheme of the targeting vector, consisting of two homology arms, a neomycin select...
<p>(A) Gene targeting strategy. The Neomycin (NeoR)/Puromycin (PuroR) selection marker is displayed ...
<p>A. Targeting vector construct <i>pTKLNCL-Cdk2ap1</i> was designed to knockout <i>Cdk2ap1</i> exon...
<p>(A) Illustration of the targeting construct and possible recombination event to produce founder m...
<p><i>A)</i> Diagram illustrating the gene-targeting strategy used to produce αB-R120G gene knock-in...
<p>A) Gene targeting strategy and restriction map of the p53 gene. Filled boxes indicate exons; labe...
<p>A part of the wild type (+) allele of mouse AQP1 is shown with indicated exons (black boxes) and ...
<p>A: Schematic of the construct used for the generation of transgenic mice expressing PA-GFP::NLS u...
<p>(A) ES-cell targeting strategy, adapted from <a href="http://www.plosone.org/article/info:doi/10....
<p>(<b>A</b>) Shows the scheme of the linearized targeting vector used for electroporation in mouse ...
<p>(a). Schematic demonstrating the strategy for targeted integration of exogenous gene(s), wild typ...
<p>(<b>A</b>) Structure of the <i>MCT1</i> wildtype allele, the targeting vector, and the resulting ...
<p>(A, E) Targeting strategies. Restriction maps of relevant genomic regions of <i>Ankrd1</i> (A) an...
<p><i>A. Targeting strategy for generating MLF1-IP KO mice</i> The red square on the 5′ side of the ...
<p>(A) Schematic diagram of the targeting construct. For targeted disruption of the mouse GlcAT-S ge...
<p><b>A</b>) Top: Scheme of the targeting vector, consisting of two homology arms, a neomycin select...
<p>(A) Gene targeting strategy. The Neomycin (NeoR)/Puromycin (PuroR) selection marker is displayed ...
<p>A. Targeting vector construct <i>pTKLNCL-Cdk2ap1</i> was designed to knockout <i>Cdk2ap1</i> exon...
<p>(A) Illustration of the targeting construct and possible recombination event to produce founder m...